Publications by authors named "Sara R Schlesinger"

Anthrax is caused by Bacillus anthracis, a bacterium that is able to secrete the toxins protective antigen, edema factor and lethal factor. Due to the high level of secretion from the bacteria and its severe virulence, lethal factor (LF) has been sought as a biomarker for detecting bacterial infection and as an effective target to neutralize toxicity. In this study, we found three aptamers, and binding affinity was determined by fluorescently labeled aptamers.

View Article and Find Full Text PDF

Metallo-β-lactamases (MBLs) that catalyze hydrolysis of β-lactam antibiotics are an emerging threat due to their rapid spread. A strain of the bacterium Bacillus anthracis has its ability to produce and secrete a MBL, referred to Bla2. To address this challenge, novel hydroxamic acid-containing compounds such as 3-(heptyloxy)-N-hydroxybenzamide (compound 4) and N-hydroxy-3-((6-(hydroxyamino)-6-oxohexyl)oxy)benzamide (compound 7) were synthesized.

View Article and Find Full Text PDF

The increasing prevalence of drug resistant bacteria is a pandemic problem. Metallo-β-lactamases (MBLs) are one of the main causes of drug resistance due to hydrolysis of β-lactam antibiotics. Thus, the development of effective inhibitors of MBLs remains urgent.

View Article and Find Full Text PDF
Article Synopsis
  • Bla2 from Bacillus anthracis hydrolyzes β-lactam antibiotics, contributing significantly to antibiotic resistance, highlighting the need for inhibitors to effectively treat anthrax infections.
  • Purification of Bla2 was achieved using Ni(2+)-affinity chromatography, resulting in a 140-fold increase in activity and a specific activity of 19,000 units/mg with a yield of 3.5%.
  • The enzyme shows varying kinetics with substrates penicillin G and cephalexin and is most active at pH levels between 7.0 and 9.0; EDTA has an IC(50) of 630 nM, indicating its potential as an inhibitor.
View Article and Find Full Text PDF

AtTDX is an enzyme present in Arabidopsis thaliana which is composed of two domains, a thioredoxin (Trx)-motif containing domain and a tetratricopeptide (TPR)-repeat domain. This enzyme has been shown to function as both a thioredoxin and a chaperone. The midpoint potential (E(m)) of AtTDX was determined by redox titrations using the thiol-specific modifiers, monobromobimane (mBBr) and mal-PEG.

View Article and Find Full Text PDF